Daiwa Securities Group
ALXN

Daiwa Securities Group’s Alexion Pharmaceuticals ALXN Stock Holding History

Daiwa Securities Group’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-16,799
Closed -$3.09M – 1368
2021
Q2 		$3.09M Buy
16,799
+957
+6% +$164K 0.02% 338
2021
Q1 		$2.42M Buy
15,842
+1,309
+9% +$202K 0.02% 365
2020
Q4 		$2.27M Buy
14,533
+841
+6% +$108K 0.02% 355
2020
Q3 		$1.57M Buy
13,692
+2,249
+20% +$243K 0.01% 393
2020
Q2 		$1.03M Hold
11,443
– – 0.02% 351
2020
Q1 		$1.03M Buy
11,443
+294
+3% +$28.9K 0.01% 458
2019
Q4 		$1.21M Sell
11,149
-1,980
-15% -$212K 0.01% 473
2019
Q3 		$1.29M Buy
13,129
+1,569
+14% +$177K 0.01% 443
2019
Q2 		$1.51M Sell
11,560
-510
-4% -$65.7K 0.01% 398
2019
Q1 		$1.63M Buy
12,070
+2,029
+20% +$252K 0.01% 379
2018
Q4 		$978K Buy
10,041
+710
+8% +$83.9K 0.01% 454
2018
Q3 		$1.3M Buy
9,331
+657
+8% +$82.4K 0.01% 452
2018
Q2 		$1.08M Buy
8,674
+200
+2% +$23.4K 0.01% 480
2018
Q1 		$945K Buy
8,474
+1,848
+28% +$221K 0.01% 505
2017
Q4 		$792K Buy
6,626
+44
+0.7% +$5.36K 0.01% 535
2017
Q3 		$923K Buy
6,582
+282
+4% +$38.3K 0.01% 469
2017
Q2 		$767K Buy
6,300
+200
+3% +$23.3K 0.01% 486
2017
Q1 		$740K Buy
6,100
+200
+3% +$25.8K ﹤0.01% 510
2016
Q4 		$722K Buy
5,900
+400
+7% +$48.9K ﹤0.01% 471
2016
Q3 		$674K Hold
5,500
– – ﹤0.01% 465
2016
Q2 		$642K Buy
5,500
+200
+4% +$28.4K ﹤0.01% 457
2016
Q1 		$738K Buy
5,300
+200
+4% +$29.4K ﹤0.01% 433
2015
Q4 		$973K Buy
5,100
+100
+2% +$17.5K 0.01% 360
2015
Q3 		$782K Buy
5,000
+500
+11% +$91.2K 0.01% 398
2015
Q2 		$813K Sell
4,500
-100
-2% -$17.3K 0.01% 429
2015
Q1 		$797K Sell
4,600
-100
-2% -$18.1K 0.01% 377
2014
Q4 		$870K Sell
4,700
-300
-6% -$55.6K 0.01% 337
2014
Q3 		$829K Sell
5,000
-300
-6% -$49.3K 0.01% 318
2014
Q2 		$828K Hold
5,300
– – 0.01% 321
2014
Q1 		$806K Sell
5,300
-400
-7% -$63.6K 0.01% 315
2013
Q4 		$757K Sell
5,700
-400
-7% -$48K 0.01% 307
2013
Q3 		$709K Sell
6,100
-200
-3% -$21.9K 0.01% 322
2013
Q2 		$581K Buy
+6,300
New +$607K ﹤0.01% 383

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $280B AUM 33.63% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return